| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $2.4 (Beat by $0.41) |
| EPS GAAP Actual | $2.4 (Beat by $0.41) |
| Revenue Actual | $2.5051B |
| Revenue Surprise | Beat by $2505.1M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.86243 |
| EPS GAAP Estimate | $1.86243 |
| Revenue Estimate | $2.303650976B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 14.005 | 37.83 | 13.37404 | 15.02477 | 1 |
| Dec 2028 | 11.49333 | 46.1 | 11.01934 | 12.07603 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.98 | 0.16649 | 2.5051B | 18.64% | 231.27M |
| FQ2 2025 (Jun 2025) | 1.84 | 0.0048400000000002 | 2.44B | 17.63% | 150.45M |
| FQ1 2025 (Mar 2025) | 1.95 | 1.95 | 2.2534B | 16.1% | 2253.4M |
| FQ4 2024 (Dec 2024) | 1.924 | 1.924 | 2.4135B | 20.1% | 2413.5M |
| FQ3 2024 (Sep 2024) | 1.59 | 1.59 | 2.0381B | 14.44% | 2038.1M |
| FQ2 2024 (Jun 2024) | 1.48 | 1.48 | 2.0099B | 12.64% | 2009.9M |
| FQ1 2024 (Mar 2024) | 1.51 | 1.51 | 1.8906B | 10.28% | 1890.6M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 1.9283B | 14.17% | 1928.3M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.86243
Consensus Revenue Estimates
2.303650976B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.98 | -- | 2.87918 | 3.04351 | 12 |
| FQ3 2027 (Sep 2027) | 2.8 | -- | 2.70527 | 2.85967 | 7 |
| FQ2 2027 (Jun 2027) | 2.71 | -- | 2.61831 | 2.76775 | 7 |
| FQ1 2027 (Mar 2027) | 2.54 | -- | 2.45406 | 2.59413 | 8 |
| FQ4 2026 (Oct 2026) | 2.11626 | -- | 2.04594 | 2.17031 | 9 |
| FQ3 2026 (Jul 2026) | 2.10784 | 6.06 | 2.0378 | 2.16168 | 9 |
| FQ2 2026 (Jun 2026) | 2.08137 | 11.6 | 2.00718 | 2.13235 | 7 |
| FQ1 2026 (Mar 2026) | 1.9323 | -0.92 | 1.86343 | 1.97963 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.38B | -- | 3.29B | 3.43B | 7 |
| FQ3 2027 (Sep 2027) | 3.13B | -- | 3.04B | 3.18B | 7 |
| FQ2 2027 (Jun 2027) | 3.08B | -- | 3B | 3.13B | 7 |
| FQ1 2027 (Mar 2027) | 2.95B | -- | 2.88B | 3B | 7 |
| FQ4 2026 (Oct 2026) | 2.58B | -- | 2.51B | 2.63B | 8 |
| FQ3 2026 (Jul 2026) | 2.58B | 3.03 | 2.52B | 2.63B | 8 |
| FQ2 2026 (Jun 2026) | 2.59B | 5.79 | 2.52B | 2.64B | 8 |
| FQ1 2026 (Mar 2026) | 2.46B | 8.37 | 2.39B | 2.51B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.81351 | 1.98 | 0.16649 | 8.41% |
| FQ2 2025 (Jun 2025) | 1.83516 | 1.84 | 0.0048400000000002 | 0.26% |
| FQ1 2025 (Mar 2025) | 1.95 | 1.95 | 100% | |
| FQ4 2024 (Dec 2024) | 1.924 | 1.924 | 100% | |
| FQ3 2024 (Sep 2024) | 1.59 | 1.59 | 100% | |
| FQ2 2024 (Jun 2024) | 1.48 | 1.48 | 100% | |
| FQ1 2024 (Mar 2024) | 1.51 | 1.51 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.27B | $2.51B | $231.27M | 9.23% |
| FQ2 2025 (Jun 2025) | $2.29B | $2.44B | $150.45M | 6.17% |
| FQ1 2025 (Mar 2025) | $0B | $2.25B | $2253.4M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.41B | $2413.5M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.04B | $2038.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.01B | $2009.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.89B | $1890.6M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.93B | $1928.3M | 100% |